REAL-WORD OUTCOMES OF MAINTENANCE CHEMOTHERAPY VERSUS AVELUMAB THERAPY AFTER FIRST-LINE INDUCTION CHEMOTHERAPY FOR ADVANCED UROTHELIAL CARCINOMA: YUSHIMA STUDY

被引：0
|
作者：
Izumi, Keita
Tanaka, Hajime
Yano, Masataka
Takazawa, Ryoji
Noro, Akira
Tsukamoto, Tetsuro
Yonese, Junji
Okuno, Tetsuo
Sakai, Yasuyuki
Koga, Fumitaka
Kageyama, Yukio
Saito, Kazutaka
Fujii, Yasuhisa
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP53-13
引用
收藏
页码：E868 / E868
页数：1
相关论文
共 50 条
  • [41] Real-world outcomes of first-line systematic treatment in advanced upper urinary tract urothelial carcinoma patients with renal impairment: YUSHIMA-04 study
    Kimura, T.
    Fujiwara, M.
    Matsumoto, S.
    Yoshitomi, K.
    Kobayashi, M.
    Fan, B.
    Nakamura, Y.
    Ishikawa, Y.
    Fukuda, S.
    Waseda, Y.
    Tanaka, H.
    Yoshida, S.
    Takazawa, R.
    Sakai, Y.
    Koga, F.
    Saito, K.
    Yano, M.
    Tsukamoto, T.
    Okuno, T.
    Kageyama, Y.
    Otsuka, Y.
    Nagahama, K.
    Fujii, Y.
    EUROPEAN UROLOGY, 2024, 85 : S813 - S814
  • [42] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Gurney, Howard
    Loriot, Yohann
    Powles, Thomas
    Duran, Climent Miguel
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    Di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 46 - 46
  • [43] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Andres
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 42 - 43
  • [44] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126
  • [45] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Powles, Thomas
    Loriot, Yohann
    Duran, Miguel A. Climent
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 132 - 133
  • [46] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Longterm outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemotherapy.
    Perez-Valderrama, Begona
    Powles, Thomas
    Sridhar, Srikala S.
    Caserta, Claudia
    Loriot, Yohann
    Gupta, Shilpa
    Bellmunt, Joaquim
    Sternberg, Cora N.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert J.
    Di Pietro, Alessandra
    Park, Se Hoon
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Capecitabine maintenance after first-line induction chemotherapy with docetaxel cisplatin, and fluorouracil in patients with advanced gastric cancer
    Oyan, Basak
    Eren, Orhan Onder
    Sonmez, Ozlem
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice
    Grivas, Petros
    Agarwal, Neeraj
    Pal, Sumanta
    Kalebasty, Arash Rezazadeh
    Sridhar, Srikala S.
    Smith, Jodi
    Devgan, Geeta
    Sternberg, Cora N.
    Bellmunt, Joaquim
    CANCER TREATMENT REVIEWS, 2021, 97
  • [49] Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder
    Chakiryan, Nicholas H.
    Jiang, Da David
    Gillis, Kyle A.
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Zhang, Jingsong
    Jain, Rohit
    Chahoud, Jad
    Li, Roger
    Sexton, Wade
    Manley, Brandon J.
    Gilbert, Scott M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (03) : 107.e11 - 107.e17
  • [50] Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma
    Hoffman-Censits, Jean
    Wong, Yu-Ning
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : 302 - 308
12345